113 related articles for article (PubMed ID: 21596235)
1. Inorganic nitrate therapy improves Doxorubicin-induced cardiomyopathy a new window for an affordable cardiovascular therapy for everyone?
Daiber A; Gori T; Münzel T
J Am Coll Cardiol; 2011 May; 57(21):2190-3. PubMed ID: 21596235
[No Abstract] [Full Text] [Related]
2. Dietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function.
Zhu SG; Kukreja RC; Das A; Chen Q; Lesnefsky EJ; Xi L
J Am Coll Cardiol; 2011 May; 57(21):2181-9. PubMed ID: 21596234
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-induced cardiomyopathy.
Muggia FM; Speyer JL
N Engl J Med; 1999 Feb; 340(8):654-5. PubMed ID: 10049088
[No Abstract] [Full Text] [Related]
4. Doxorubicin-induced cardiomyopathy.
Lipshultz SE; Grenier MA; Colan SD
N Engl J Med; 1999 Feb; 340(8):653-4; author reply 655. PubMed ID: 10049085
[No Abstract] [Full Text] [Related]
5. Prenylamine inhibition of adriamycin-induced cardiomyopathy in mice.
Milei J; Bolomo NJ; Marantz A
Medicina (B Aires); 1982; 42(4):409-14. PubMed ID: 15171023
[No Abstract] [Full Text] [Related]
6. Doxorubicin-induced myocardial injury.
Fujisaki G; Inokuchi C; Murashige N
N Engl J Med; 2004 Oct; 351(18):1908-9; author reply 1908-9. PubMed ID: 15509827
[No Abstract] [Full Text] [Related]
7. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.
Octavia Y; Tocchetti CG; Gabrielson KL; Janssens S; Crijns HJ; Moens AL
J Mol Cell Cardiol; 2012 Jun; 52(6):1213-25. PubMed ID: 22465037
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-induced cardiomyopathy.
Singal PK; Iliskovic N
N Engl J Med; 1998 Sep; 339(13):900-5. PubMed ID: 9744975
[No Abstract] [Full Text] [Related]
10. Concurrent therapies that protect against doxorubicin-induced cardiomyopathy.
Simpson C; Herr H; Courville KA
Clin J Oncol Nurs; 2004 Oct; 8(5):497-501. PubMed ID: 15515283
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and prevention of doxorubicin cardiomyopathy.
Ferrans VJ; Clark JR; Zhang J; Yu ZX; Herman EH
Tsitologiia; 1997; 39(10):928-37. PubMed ID: 9505340
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy.
Simsir SA; Lin SS; Blue LJ; Gockerman JP; Russell SD; Milano CA
Ann Thorac Surg; 2005 Aug; 80(2):717-9. PubMed ID: 16039240
[TBL] [Abstract][Full Text] [Related]
13. Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumor suppression.
Kuramochi Y; Takagi H; Morita T
Eur Heart J; 2006 Nov; 27(21):2610-1; author reply 2611. PubMed ID: 17018546
[No Abstract] [Full Text] [Related]
14. Dietary fish oil does not prevent doxorubicin-induced cardiomyopathy in rats.
Matsui H; Morishima I; Hayashi K; Kamiya H; Saburi Y; Okumura K
Can J Cardiol; 2002 Mar; 18(3):279-86. PubMed ID: 11907617
[TBL] [Abstract][Full Text] [Related]
15. Can dexrazoxane reduce myocardial injury in anthracycline-treated children with acute lymphoblastic leukemia?
Silber JH
Nat Clin Pract Oncol; 2004 Nov; 1(1):16-7. PubMed ID: 16264791
[No Abstract] [Full Text] [Related]
16. Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice.
Riad A; Bien S; Westermann D; Becher PM; Loya K; Landmesser U; Kroemer HK; Schultheiss HP; Tschöpe C
Cancer Res; 2009 Jan; 69(2):695-9. PubMed ID: 19147586
[TBL] [Abstract][Full Text] [Related]
17. Effects of dexrazoxane and amifostine on evolution of Doxorubicin cardiomyopathy in vivo.
Bjelogrlic SK; Radic J; Radulovic S; Jokanovic M; Jovic V
Exp Biol Med (Maywood); 2007 Dec; 232(11):1414-24. PubMed ID: 18040065
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of aliskiren in doxorubicin-induced acute cardiomyopathy in rats.
Rashikh A; Abul Kalam Najmi ; Akhtar M; Mahmood D; Pillai KK; Ahmad SJ
Hum Exp Toxicol; 2011 Feb; 30(2):102-9. PubMed ID: 20418268
[TBL] [Abstract][Full Text] [Related]
19. Recovery from anthracycline cardiomyopathy--how can it be explained?
Christiansen S
J Heart Lung Transplant; 2009 Jul; 28(7):751. PubMed ID: 19560709
[No Abstract] [Full Text] [Related]
20. Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice.
Hou G; Dick R; Abrams GD; Brewer GJ
J Lab Clin Med; 2005 Nov; 146(5):299-303. PubMed ID: 16242529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
